DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This clinical trial is being performed to investigate the effect of 12 weeks treatment with
rosuvastatin and atorvastatin in bringing subjects to their established EAS LDL-C target
goal.